pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
CRO/CDMO · news · pharmadog
← back to CRO/CDMO
News · CRO/CDMO
56
stories
23d
Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy
biospace
24d
The FDA was all in on AI. Will that change?
biopharma dive
24d
Acrosian debuts as AI-focused biometrics CRO
fiercebiotech
24d
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
biospace
25d
From confidence to capital: Positioning biotech for the next growth cycle
biopharma dive
25d
FDA has recommitted to adcomms—but to what end?
biospace
29d
From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech
fiercebiotech
29d
Repligen’s $1.5B buy for BioLife; BeOne’s $300M US expansion
endpoints
29d
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
biospace
Jul 22, 26
House passes bill directing FDA to update animal testing rules
fiercebiotech
Jul 21, 26
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
biospace
Jul 20, 26
Samsung Bio to step into peptides in $1.8B buy for PolyPeptide
endpoints
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jul 15, 26
Insilico, Bora Pharma reveal plans for AI-driven manufacturing company
endpoints
Jul 9, 26
Catalent to divest UK site; Rottendorf, Evonik announce manufacturing builds
endpoints
Jul 2, 26
Galderma gets CRL for anti-wrinkle drug; Kimball buys CDMO for $103M
endpoints
Jul 2, 26
STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong
stat
Jun 30, 26
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
biopharma dive
Jun 15, 26
Planning a successful pivot from lab to clinic
biopharma dive
Jun 8, 26
Innovation alone is no longer enough in biopharma
biopharma dive
May 19, 26
Full-Life Technologies raises $150M; Quince's reboot with pulmonary drug
endpoints
May 14, 26
MacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attack
endpoints
May 6, 26
Lonza looks to ride ADC wave with upcoming factory, workforce expansion
endpoints
May 5, 26
Microbiome startup raises $48M for immunotherapy and malnutrition treatments
endpoints
Apr 27, 26
Thermo Fisher sells microbiology biz; Ligand to buy XOMA
endpoints
Apr 27, 26
Opinion: I’m a fourth-year med student, but I only learned one historical example of medical racism
stat
← prev
page 2 of 2
next →
